Clinical Trials Logo

Syncope, Vasovagal clinical trials

View clinical trials related to Syncope, Vasovagal.

Filter by:

NCT ID: NCT02324920 Completed - Syncope Clinical Trials

Benefit of Dual-chamber Pacing With Closed Loop Stimulation (CLS) in Tilt-induced Cardioinhibitory Reflex Syncope

BIOSync CLS
Start date: October 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether the Closed Loop Stimulation (CLS) in addition to the DDD pacing is effective in reducing syncopal recurrences. The study hypothesis is that DDD pacing with CLS stimulation is able to prevent syncopal recurrences completely or partially by transforming syncope in pre-syncope.

NCT ID: NCT02140567 Completed - Vasovagal Syncope Clinical Trials

Syncope Prediction Study

SPS
Start date: November 2014
Phase:
Study type: Observational

The purpose of this study is to perform a prospective evaluation of the vasovagal syncope prediction algorithm, called Tilt Test Analyzer, during head up tilt testing tests in one center in the United Kingdom.

NCT ID: NCT02009982 Completed - Vasovagal Syncope Clinical Trials

Cardioneuroablation for Neurocardiogenic Syncope

Ablate-NCS
Start date: December 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of cardioneuroablation for the treatment of neurocardiogenic syncope (NCS), also known as "vaso-vagal" syncope. Syncope is a general term for passing out spells and neurocardiogenic syncope is a specific form of passing out spells caused by sudden drops in heart rate or blood pressure. Although the specific mechanisms of NCS are not well understood, it is believed that some people are prone to developing passing out spells in specific situations such as standing up for a long period of time, pain or nausea. In these situations, the body reacts with a paradoxical reflex which leads to a drop in blood pressure and heart rate and causes passing out. Certain types of medications are used to treat NCS including beta-blockers, midodrine and florinef, among others. However, none of these medications are particularly effective at preventing passing out spells and many people continue to have episodes despite trying different medications. Cardioneuroablation is a new form of treatment for NCS. The term ablation means using a wire to make small electrical burns in the heart. Ablation has been used for many years to treat other electrical disturbances in the heart but the use of ablation to treat NCS is a new application. The goal of cardioneuroablation is to identify areas within the heart which are believed to initiate the reflex which triggers the drop in heart rate and blood pressure that leads to passing out. In preliminary studies, it has been suggested that cardioneuroablation may be significantly more effective than medications at preventing passing out spells for people with NCS. Hypothesis: Cardioneuroablation of vagal inputs in the left atrium may serve as an effective treatment modality for the prevention of NCS by blunting the initial trigger of the cascade that leads to symptoms and syncope.

NCT ID: NCT01926561 Completed - Syncope, Vasovagal Clinical Trials

Predictive Factors for Hypotensive Bradycardic Events During Arthroscopic Shoulder Surgery

Start date: August 2011
Phase: N/A
Study type: Observational

Patients's demographics and perioperative factors affect the occurrence of hypotensive bradycardic events in the patients undergoing arthroscopic shoulder surgery in the sitting position under interscalene block.

NCT ID: NCT01695525 Completed - Syncope, Vasovagal Clinical Trials

Influence of Yoga in Patients With Neurocardiogenic Syncope

SYNC - YOGA
Start date: June 2012
Phase: Phase 0
Study type: Interventional

Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping skills. It has been established that practice of Yoga could relieve stress and anxiety. In a different study, they also found that Yoga positively influences cardiovascular function by decreasing the heart rate and blood pressure. The main objective of Yoga is to achieve control over the autonomic nervous system and able to control functions like heart rate, blood pressure and respiratory rate. Based on the findings that Yoga relieves stress and reduces heart rate, the investigators propose to study if Yoga can decrease the frequency of NCS and also reduce the symptoms associated with these episodes.

NCT ID: NCT01617616 Completed - Clinical trials for Postural Orthostatic Tachycardia Syndrome

Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects

POTS
Start date: March 2012
Phase: N/A
Study type: Observational

Dysautonomia, primarily defined as postural orthostatic tachycardia syndrome (POTS) can seriously disrupt a child's daily activities. It is most commonly associated with nausea or abdominal pain. In preliminary studies, when orthostatic intolerance was treated with fludrocortisone, a standard therapy for orthostatic intolerance (OI), symptomatic improvement in nausea was observed. However, children with POTS were also observed to have higher supine mean arterial pressure (MAP) (preliminary data) and greater suppression of the baroreceptor reflex sensitivity (BRS) occurred upon up-right tilt. While fludrocortisone alleviates nausea associated with OI, its long-term use may pose long term health risks to children including worsening hypertension. Therefore, it is the objective of this study to define the mechanism for OI as it relates to nausea. The investigators hypothesize that OI resulting from changes in the autonomic nervous system is the likely mechanism for the nausea observed in the patients in this study. The investigators further hypothesize that this is potentially an early marker for future cardiovascular problems such as early onset hypertension and cardiac hypertrophy. The general objective of this protocol is to address this gap in knowledge by determining the autonomic characteristics of children with OI as well as defining neurohumoral profiles for these subjects to better understand the cause of the elevated supine in these subjects. By better understanding the potential mechanism for this condition, it is the investigators future goal to develop a more focused and safer treatment strategy. The investigators will study subjects between 10 to 18 years of age utilizing the tilt table to mimic daily life stressors and also measure serum levels of epinephrine, norepinephrine, rennin, angiotensin II, aldosterone, and vasopressin at baseline and during tilt. This study will generate data with high impact in that more rational treatments for management of dysautonomia could be chosen on the basis of the profile of dysautonomia and neurohumoral markers.

NCT ID: NCT00475462 Completed - Syncope, Vasovagal Clinical Trials

The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents

Start date: July 2001
Phase: N/A
Study type: Interventional

The purpose of this study to evaluate the effectiveness of metoprolol versus conventional treatment in the prevention of syncope recurrence in children and adolescents.

NCT ID: NCT00465439 Completed - Syncope, Vasovagal Clinical Trials

Safety/Efficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal

Start date: May 2007
Phase: N/A
Study type: Interventional

This randomized controlled trial will examine the impact of local anesthetic on the frequency of vasovagal reactions and the patients perception of pain during femoral arterial sheath removal after percutaneous coronary intervention.

NCT ID: NCT00302900 Completed - Syncope, Vasovagal Clinical Trials

Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations

Start date: January 2006
Phase: Phase 2
Study type: Interventional

Many individuals experience negative reactions when donating blood, including dizziness, lightheadedness, or fainting. Such reactions may discourage them from donating again. This study will evaluate the effectiveness of pre-donation water consumption and a muscle tensing exercise during donation to reduce negative reactions among new blood donors. This study will also evaluate whether reducing negative reactions increases the likelihood of donors returning to give blood in the future.

NCT ID: NCT00292825 Completed - Vasovagal Syncope Clinical Trials

Effect of Closed Loop Pacemaker Treatment on Recurrent Vasovagal Syncope

Start date: February 2006
Phase: N/A
Study type: Interventional

The main purpose is to prevent syncope in patients with recurrent syncopal episodes caused by malignant vasovagal faints and bradycardia. Patients are treated by a special pacemaker (closed loop stimulation [CLS]) which can potentially identify an incipient attack and prevent syncope by pacing.